Finance

Beta
Lists
07X:FRA
Annovis Bio Inc
€1.52
-6.29%
(-0.10) 1D
Jul 14, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 07X...
Open
€1.52
High
€1.52
Low
€1.52
Mkt. cap
59.25M
Avg. vol.
1.16K
Volume
0.00
52-wk high
€4.61
52-wk low
€1.35
No. of employees
8
Open
€1.52
High
€1.52
Low
€1.52
Mkt. cap
59.25M
Avg. vol.
1.16K
Volume
0.00
52-wk high
€4.61
52-wk low
€1.35
No. of employees
8
News stories
From sources across the web
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.16M
6.29M
8.75M
16.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11M
1.14M
955.15K
1.19M
Operating expense
6.27M
7.43M
9.71M
17.91M
Total operating expenses
6.27M
7.43M
9.71M
17.91M
Operating income
-6.27M
-7.43M
-9.71M
-17.91M
Other non operating income
-140.00K
20.00K
-296.00K
268.00K
EBT including unusual items
-6.22M
-7.26M
-9.83M
-17.61M
EBT excluding unusual items
-6.22M
-7.26M
-9.83M
-17.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.22M
-7.26M
-9.83M
-17.61M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.37
-0.39
-0.63
Interest and investment income
191.40K
152.32K
167.74K
137.80K
Interest expense
-
-
-
-
Net interest expenses
191.40K
152.32K
167.74K
137.80K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more